Enanta Pharmaceuticals
ENTA
ENTA
181 hedge funds and large institutions have $1.19B invested in Enanta Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 59 increasing their positions, 51 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
16% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 51
3.57% more ownership
Funds ownership: 73.38% → 76.95% (+3.6%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
181
Holding in Top 10
2
Calls
$4.22M
Puts
$1.21M
Top Buyers
| 1 | +$40M | |
| 2 | +$15.8M | |
| 3 | +$10.1M | |
| 4 |
Bank of New York Mellon
New York
|
+$6.09M |
| 5 |
Renaissance Technologies
New York
|
+$5.93M |
Top Sellers
| 1 | -$17.2M | |
| 2 | -$12.8M | |
| 3 | -$10.6M | |
| 4 |
KAM
Krensavage Asset Management
New York
|
-$10.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$5.94M |